Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma sodium and hypertension.

Hugh E de Wardener1, Feng J He, Graham A MacGregor

  • 1Department of Clinical Chemistry, Imperial College, Charing Cross Hospital Campus, London, United Kingdom.

Kidney International
|December 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing Sodium Reduction Strategy: Context-Specific Frameworks Targeting Main Dietary Sources.

Advances in nutrition (Bethesda, Md.)·2026
Same author

Healthy dietary patterns, longevity genes, and life expectancy: A prospective cohort study.

Science advances·2026
Same author

New pharmacological therapies for hypertension.

Current opinion in nephrology and hypertension·2026
Same author

Professor Graham A. MacGregor, CBE, MBBS, FRCP, FMedSci (1941-2025).

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Risk factors for cancer among the working population in China: a cross-sectional analysis of baseline data from the WECAN project.

BMJ open·2025
Same author

Professor Graham A. MacGregor, CBE, MBBS, FRCP, FMedSci (1941-2025).

Hypertension (Dallas, Tex. : 1979)·2025
Same journal

Why current evidence does not support routine C5 inhibition in STEC-HUS.

Kidney international·2026
Same journal

Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
See all related articles

Dietary salt intake can increase blood pressure through mechanisms beyond fluid volume. A small rise in plasma sodium concentration may directly contribute to hypertension, independent of extracellular fluid volume expansion.

Area of Science:

  • Cardiovascular Physiology
  • Renal Physiology
  • Hypertension Pathophysiology

Background:

  • Dietary salt is a primary driver of age-related blood pressure increase and population-level hypertension.
  • Current understanding primarily focuses on extracellular fluid volume (ECV) expansion as the mechanism for salt-induced hypertension.
  • The precise mechanisms by which salt intake elevates blood pressure remain incompletely understood.

Purpose of the Study:

  • To investigate the role of plasma sodium concentration in mediating the pressor effects of dietary salt.
  • To explore whether elevated plasma sodium independently contributes to blood pressure elevation.
  • To examine the direct effects of increased plasma sodium on vascular tissue and the brain-renin-angiotensin system.

Main Methods:

Related Experiment Videos

  • Review of existing concepts on salt intake and blood pressure regulation.
  • Analysis of evidence linking plasma sodium levels to essential hypertension and spontaneously hypertensive rats (SHR).
  • Discussion of experimental data on the pressor effects of induced plasma sodium concentration changes in biological systems.

    • Main Results:

    • Increased salt intake leads to a small rise in plasma sodium, promoting fluid shift to extracellular space and stimulating thirst.
    • Evidence suggests plasma sodium may be elevated by 1-3 mmol/L in hypertensive individuals and SHR.
    • Experimental sodium increases >5 mmol/L induce pressor effects on the brain and renin-angiotensin system, and alter vascular tissue.

    Conclusions:

    • A modest increase in plasma sodium concentration may be a significant factor in salt-induced hypertension.
    • This mechanism operates independently of, or in addition to, extracellular fluid volume expansion.
    • Elevated plasma sodium may directly impact cardiovascular regulation and vascular health.